首页> 外文OA文献 >Results of a prospective observation on the use of a coagulation factor concentrate VIII concentrate (Octanate®) for the induction of immunological tolerance in patients with an inhibitory form of hemophilia A

【2h】

Results of a prospective observation on the use of a coagulation factor concentrate VIII concentrate (Octanate®) for the induction of immunological tolerance in patients with an inhibitory form of hemophilia A

机译：对凝血因子浓缩物（辛烷酸酯）使用凝血因子浓缩物（Octanate®）诱导血友病患者免疫耐受性的前瞻性观察结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
N. I. Zozulya; V. V. Vdovin; P. V. Svirin; T. A. Andreeva; E. E. Shiller; N. I. Konyashina; I. A. Lavrichenko; O. E. Zalepukhina; N. I. Klimova; V. N. Konstantinova; O. A. Krasheninnikova; V. Yu. Petrov; F. G. Perina; N. S. Osmulskaya; A. V. Mironova; N. A. Popova;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. OBSERVATIONAL IMMUNE TOLERANCE INDUCTION STUDY (OBSITI): IMMUNE TOLERANCE INDUCTION WITH A SINGLE FACTOR VIII/VON WILLEBRAND FACTOR CONCENTRATE FOR TREATMENT OF HEMOPHILIA A PATIENTS WITH INHIBITORS [J] . Escuriola-Ettinghausen C. Archives of disease in childhood . 2019,第Suppla1期

机译：观察免疫耐受性诱导研究（Obsiti）：用单一因子VIII / von Willebrand因子浓缩物用于治疗血友病患者抑制剂患者的免疫耐受性诱导
2. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study [J] . Kreuz W., Ettingshausen C. Escuriola, Vdovin V., Haemophilia: the official journal of the World Federation of Hemophilia . 2016,第1期

机译：关于低风险血友病A抑制剂患者中具有单因子VIII / von Willebrand因子的免疫耐受的第一份前瞻性报告集中在观察性免疫耐受诱导研究中
3. Treatment of Haemophilia a (HA) Patients with Inhibitors: Immune Tolerance Induction with a Single Factor VIII/Von Willebrand Factor Concentrate in an Observational Immune Tolerance Induction Study (ObsITI) [J] . Ettingshausen C. Escuriola, Berntorp Erik, Dargaud Yesim, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：嗜血症A（HA）抑制剂患者的治疗：在观察免疫耐受诱导研究中浓缩单因素VIII / von Willebrand因子浓缩物的免疫耐受性诱导（Obsiti）
4. Inactiwatlon of Animal Factor VIII by human Factor VIII Inhibitors: Inwestigation of Plasma from Patients with Inhibitors in congenital Hemophilia I and from Patients with acquired Hemophilia A [C] . V. Aumann, G. Lutze (Jr.), G. Lutze (Sen.), Hemophilie-Symposion . 2003

机译：人为因子VIII抑制剂的动物因子VIII的乙酰丁酮：先天性血友病药中抑制剂患者的血浆中的预防
5. Immunity and tolerance to coagulation co-factor VIII in the treatment of hemophilia A. [D] . Skupsky, Jonathan. 2009

机译：血友病A治疗中对凝血因子VIII的免疫力和耐受性。
6. Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate. [O] . C. Tsoukas, F. Gervais, A. Fuks, 1983

机译：接受冻干的VIII因子浓缩物和冷沉淀的经典血友病患者的免疫功能障碍。
7. Immune tolerance induction using a factor VIII/von Willebrand factor concentrate (BIOSTATE®), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: A multicentre, retrospective study [O] . Robertson Jeremy D., Higgins Pauline, Price Jamie, 2014

机译：在澳大利亚小儿重度血友病中使用VIII因子/ von Willebrand因子浓缩物（BIOSTATE®）进行免疫耐受诱导（有或没有免疫抑制作用）A高滴度抑制剂的患者：一项多中心回顾性研究

Results of a prospective observation on the use of a coagulation factor concentrate VIII concentrate (Octanate®) for the induction of immunological tolerance in patients with an inhibitory form of hemophilia A

著录项

引文网络

相似文献

相关主题

期刊订阅